Be Ahead With Economy And Policy Updates
Mumbai: GSK announced the availability of its much-awaited advanced therapies Jemperli (dostarlimab) and Zejula (niraparib) in India, marking its commitment to addressing the
Greater Noida (Staff Correspondent): Earlier today, the Promoter Group of Apollo Hospitals, represented by Suneeta Reddy, sold 1,897,239 equity shares, amounting to 1.3%
Greater Noida: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for
New Jersey: Glenmark Pharmaceuticals Inc., USA (Glenmark) has announced to launch1 of Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial).
Mumbai: In a concentrated effort to address the growing challenge of iron deficiency and inadequate protein intake among young children, Danone India joined
Mumbai: Indoco Remedies Ltd. announced final approval of the Company’s Abbreviated New Drug Application (ANDA) for Rivaroxaban Tablets USP, 2.5 mg, 10 mg,
Mumbai: Chemkart India Limited (CIL), a leading B2B nutraceutical ingredient distributor and processor, is proud to announce that its wholly owned subsidiary, Easy
Hyderabad: Sigachi Industries Limited, India’s leading manufacturer of pharmaceutical excipients, APIs, and specialty ingredients, has announced the initiation of civil works for its
Mumbai: Wanbury Ltd., a pharmaceutical company with a presence in the global API market and domestic branded formulations, has announced its financial results
Mumbai: Allied Digital Services Limited, a global provider of IT services and a Master System Integrator (MSI), has announced that it has been
Newsletter
Persistent Wins CII Award for Excellence in Disability Inclusion
Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg
BCPL Railway Infra Bags Rs. 46.18 Million Work Under Sealdah Division of Eastern Railway
Intense Technologies Announces Retirement of Founder C.K. Shastri
ACS Technologies Achieves CMMI Maturity Level 3 Appraisal For DEV and SVC Domains